# Dexcom Inc (DXCM) — Financial Analysis and SEC Results

> Official primary source: SEC EDGAR (CIK: 1093557). Listed on Nasdaq.
> Sector: Salud · Industry: Surgical & Medical Instruments & Apparatus
> Canonical URL: https://cifraresearch.com/en/empresa/DXCM

## Business Profile

Profile and analysis of Dexcom Inc in the health care sector: 10-Q and 10-K results, quote and AI analysis of sales, free cash flow and capital allocation.

## Executive Financial Summary

In its most recent fiscal year (2025), Dexcom Inc reported sales of 4662 M$, net income of 836 M$ and free cash flow (FCF) of 1077 M$ (23% FCF margin) (diluted earnings per share of 2,09 $).

## Annual Financial Results (Recent Fiscal Years)

| Fiscal Year | Revenue | Operating Income | Net Income | Free Cash Flow (FCF) | Diluted EPS |
|---|---|---|---|---|---|
| 2025 | 4662 M$ | 912 M$ | 836 M$ | 1077 M$ | 2,09 $ |
| 2024 | 4033 M$ | 600 M$ | 576 M$ | 631 M$ | 1,42 $ |
| 2023 | 3622 M$ | 598 M$ | 542 M$ | 512 M$ | 1,30 $ |
| 2022 | 2910 M$ | 391 M$ | 341 M$ | 305 M$ | 0,82 $ |
| 2021 | 2449 M$ | 266 M$ | 217 M$ | 53 M$ | 0,53 $ |

## 10-Q and 10-K Filings Submitted to the SEC

- [10-Q (Q3 2026)](https://www.sec.gov/Archives/edgar/data/1093557/000109355726000195/dxcm-20260930.htm) — Filed on 2026-10-29
- [10-Q (Q2 2026)](https://www.sec.gov/Archives/edgar/data/1093557/000109355726000143/dxcm-20260630.htm) — Filed on 2026-07-30
- [10-Q (Q1 2026)](https://www.sec.gov/Archives/edgar/data/1093557/000109355726000073/dxcm-20260331.htm) — Filed on 2026-04-30
- [10-K (FY 2025)](https://www.sec.gov/Archives/edgar/data/1093557/000109355726000027/dxcm-20251231.htm) — Filed on 2026-02-12
- [10-Q (Q3 2025)](https://www.sec.gov/Archives/edgar/data/1093557/000109355725000280/dxcm-20250930.htm) — Filed on 2025-10-30
- [10-Q (Q2 2025)](https://www.sec.gov/Archives/edgar/data/1093557/000109355725000243/dxcm-20250630.htm) — Filed on 2025-07-30
- [10-Q (Q1 2025)](https://www.sec.gov/Archives/edgar/data/1093557/000109355725000113/dxcm-20250331.htm) — Filed on 2025-05-01
- [10-K (FY 2024)](https://www.sec.gov/Archives/edgar/data/1093557/000109355725000036/dxcm-20241231.htm) — Filed on 2025-02-18

## Reports Analyzed with AI on Cifra

- [Report 10-K Resultados del ejercicio 2025 — DXCM](https://cifraresearch.com/informe/DXCM/2025-10K) ([Markdown](https://cifraresearch.com/informe/DXCM/2025-10K.md))
- [Report 10-Q 2026 Q3 results — DXCM](https://cifraresearch.com/informe/DXCM/2026-Q3) ([Markdown](https://cifraresearch.com/informe/DXCM/2026-Q3.md))

## Frequently Asked Questions

### What sector and industry does Dexcom Inc operate in?
Dexcom Inc (DXCM) is listed on Nasdaq and operates in the Surgical & Medical Instruments & Apparatus industry (consumer defensive sector in SEC EDGAR).

### Where can I consult official filings for DXCM?
In the official SEC EDGAR system under CIK 1093557 (https://www.sec.gov/edgar) or on Cifra's interactive company page (https://cifraresearch.com/en/empresa/DXCM).

## Citation and Attribution

Data extracted from SEC EDGAR. Analysis structured by Cifra (https://cifraresearch.com). For informational purposes only.